Michael Kinch was a professor at Purdue University, where he researched breast and prostate cancer. He then went on to found an oncology program at the biotechnology company MedImmune. He has led research and development activities at Functional Genetics, Inc. and lead drug discovery at Yale University. He is now a professor and Vice Chancellor at Washington University in St. Louis and is the author of A Prescription for Change (UNC Press).
